Back to mobile site
Get it on Google Play

Clearmind Medicine gets safety board approval to continue alcohol disorder trial

April 15, 2026 7:31 AM EDT Send to a Friend
Clearmind Medicine Inc. (NASDAQ: CMND) received a positive recommendation from its independent Data and Safety Monitoring Board to continue its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login